First of all I have read the article in the link a few times and I do not see where one can directly infer that the new Innovative Medicine branch has three sub-domains mapping directly to our pipeline. Yes, there is are a lot of areas in Pfizer's new model which bode well for IPIX to fit in nicely, but the article still seems a little vague to me as to the exact structure of their new divisions. Regardless, your comment can only be interpreted in the manner as to validate that the post you were responding to was factual information gleaned from the article. So you either didnt read the article, didnt really read the the content of the post, or you wanted to validate the post because it helps your current narrative of bullishness. All red flags to me.